Ribo and Boehringer Ingelheim further progress their siRNA program for metabolic dysfunction-associated steatohepatitis (MASH)

onsemi Announces Proposed Private Offering of $1.3 Billion of Convertible Senior Notes

TIC Solutions to Host and Webcast 2026 Investor Day on May 19, 2026

X4 Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Corporate Update

Bausch + Lomb Announces Second R&D "Teach-in" Webinar

REGENXBIO to Host Webcast on May 14 to Discuss Topline Results from Pivotal Trial of RGX-202 for Duchenne Muscular Dystrophy

Cyngn Announces Date for First Quarter 2026 Financial Results

Lifecore Biomedical Reports Financial Results for the First Quarter Ended March 31, 2026, and Provides Corporate Update

Metropolitan Bank Holding Corp. Named to 2026 KBW Bank Honor Roll

NRG Energy Reports First Quarter 2026 Results and Reaffirms 2026 Financial Guidance

The New York Times Company Reports First-Quarter 2026 Results

Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia in Germany

EyePoint Reports First Quarter 2026 Financial Results and Highlights Recent Corporate Developments

Energous Wireless Power Solutions to Participate in Fireside Chat at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio

Tempest Presents Clinical Update at ISCT 2026 Annual Meeting

Blaize Announces Pricing of $35 Million Public Offering of Common Stock

Royalty Pharma reports first quarter 2026 results

NIQ Launches AI-Powered Platform to Help Brands Test Pricing Decisions Before They Go to Market

Sprott Announces First Quarter 2026 Results